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Abstract
Background In patients undergoing surgical interventions
under general anesthesia, obstructive sleep apnea syndrome
(OSA) can cause serious perioperative cardiovascular or
respiratory complications leading to fatal consequences,
even sudden death. In this study we test the hypothesis that
morbidly obese patients diagnosed by a polysomnography
test and using continuous positive airway pressure (CPAP)
therapy have fewer and less severe perioperative compli-
cations and a shorter hospital stay than patients who have a
medical history that meets at least three STOP-Bang cri-
teria and are not using CPAP therapy.
Methods Postoperative hospital stay and pulmonary
complications were analyzed in three groups of morbidly
obese patients undergoing bariatric surgery (Roux-en-Y
gastric bypass and laparoscopic sleeve gastrectomy)
between January 2009 and November 2013 (n = 693).
Group A comprised 99 patients who were preoperatively
diagnosed with OSA based on polysomnography results.
These patients used CPAP therapy before and after surgery.
Group B consisted of 182 patients who met at least three
STOP-Bang criteria but who were not diagnosed with OSA
based on polysomnography results. These patients did not
use CPAP. Group C, the reference group, comprised 412
patients who scored one to two items on the STOP-Bang.
Results During the perioperative period, Group B patients
had a significantly (p \ 0.001) higher cumulative rate of
pulmonary complications, worse oxygen saturation, respi-
ratory rates, and increased length of stay in hospital. There
was also two cases of sudden death in this group.
Conclusion Based on these results, we conclude that
patients meeting at least three STOP-BANG criteria have
higher postoperative complications and an increased length
of hospital stay than patients using CPAP.
Keywords Obstructive sleep apnea syndrome  Morbid
obesity  Postoperative complications  Sudden death
Introduction
One of the most common sleep disorders is sleep apnea,
and it is believed that approximately 1–10 % of adults are
affected by obstructive sleep apnea syndrome (OSA). OSA
is characterized by decreased rates of breathing or an
absence of breathing during sleep [1] and is a well-known
risk factor associated with morbidly obese individuals [2].
In obese patients, OSA is attributed to a reduction in
pharyngeal cross-sectional area due to peripharyngeal fat
deposition [3]. In patients undergoing bariatric surgery,
OSA is a risk factor for postoperative complications, such
as cardiac arrhythmias and decompensation, pulmonary
embolism and sudden death [4–8]. The exact mechanisms
underlying these associations are complex and not yet fully
understood [9]. The cardio-respiratory consequences of
OSA may exacerbate in the postoperative period due to the
adverse effect of general anesthetics and pain treatment for
breathing control and upper airways muscle tone. Based on
such information, many authors have suggested that it is
important to identify patients suffering from OSA [11, 12].
Earlier studies of preoperative sleep disorders prior to ba-
riatric surgery demonstrated an overall prevalence rate of
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OSA ranging from 48 to 91 % [13, 14]. Not all morbidly
obese patients are routinely tested and diagnosed for OSA
by a polysomnography (PSG) test, which is a test that
enables OSA to be diagnosed objectively [15, 16]. Patients
diagnosed for OSA receive the advice to use continuous
positive airway pressure (CPAP), which is effective in
treating obstructive sleep apnea [17, 18]. Clinicians often
use the STOP-Bang questionnaire to estimate the OSA risk
involved [19] as this questionnaire has a well predictive
power [20, 21]. The likelihood of having moderate or
severe OSA increases with each point increase in the
STOP-bang score. In our hospital we observed that patients
not using CPAP due to the absence of a diagnosis for OSA
based on a PSG test had more complications and increased
length of hospital stay (LOS) than those who did. An
increased LOS limits the capacity of the hospital system
and hence contributes to a poorer economic performance.
In this study we hypothesize that morbidly obese patients
diagnosed with OSA by a PSG test and using CPAP have
fewer perioperative complications and a shorter hospital
stay than those who have a medical history which meets at
least three STOP-Bang criteria and who are not using
CPAP.
Patients and methods
After Institutional Review Board (IRB) approval for the
study was obtained, data on all patients undergoing bari-
atric surgery between January 2009 and November 2013
were collected. The need for consent was waived by our
IRB due to the entirely retrospective nature of the study.
During the study period, based on a prospective database,
693 patients underwent bariatric surgery in the Department
of General, Endocrine and Transplant Surgery, Medical
University of Gdan´sk, Poland. The scheduling of patients
for the operation was based on their arrival in the hospital,
on a first-come first-served basis. Criteria for patient eli-
gibility for bariatric surgery include the following [22]: (1)
age range 18–65; (2) weight of [45 kg above the ideal
body weight for sex and height; (3) body mass index (BMI)
of [40 kg/m2 by itself or [35 kg/m2 in the case of an
associated comorbidity such as diabetes or sleep apnea; (4)
obesity-related health problems; (4) reasonable attempts at
other weight loss techniques; (5) no psychiatric or drug
dependency problems; (6) capacity to understand the risks
and commitment associated with the surgery; (7) preg-
nancy not anticipated in the first 2 years following surgery.
Criteria for exclusion from the study were emergency or
urgent surgery required within 48 h and patients with
trauma or who were critically ill patients. The performed
surgical procedures were Roux-en-Y gastric bypass
(RYGB) and laparoscopic sleeve gastrectomy (LSG). As a
part of the bariatric protocol, all patients, both those
diagnosed and not diagnosed for OSA, were asked to fill in
the STOP-Bang questionnaire. STOP-Bang scoring was
conducted by trained personnel.
Patient groups
We divided the patients into three groups, as follows:
Group A: This group consisted of patients with preop-
eratively diagnosed OSA based on PSG test
results. The test was performed in our hospital
or in other clinics before these patients
allowed to enrol in the bariatric pathway
program, and the results were added to the
patient file. The patients in this group used
CPAP at home pre- and postoperatively, and
none of these patients had been treated
surgically to solve OSA. These patients also
brought their own CPAP mask to the hospital.
Patients accepted for surgery were informed
by the surgeon about the health benefits of
using CPAP, and they were asked to imme-
diately inform the outpatient department when
they were not able to comply. This (and the
reason why) was noted in the patient file. The
CPAP apparatus records compliance data in
order to provide the necessary information,
such as usage (in hours) per night. Current
trends define compliance as 4 h per night as an
average over all nights observed [23]. We
measured compliance from the second week
of CPAP usage until a day before the sched-
uled surgery.
Group B: This group consists of patients not diagnosed
for OSA by use of the PSG test and patients
who underwent a PSG test and were not
diagnosed for OSA. Patients in group B
complied to at least three STOP-Bang criteria
and did not use CPAP.
Group C: This group consists of patients scoring one to
two items on the STOP-Bang question-
naire,indicating that they have a low risk for
OSA.
In all groups during the preoperative, intraoperative and
postoperative phases, standardized multimodal analgesia,
antiemesis and thromboprophylaxis were given. For
induction, this included piritramide 20 mg, propofol
200–400 mg, suxamethonium 100–200 mg, granisetron
3 mg, dexamethasone 8 mg. For maintenance, this inclu-
ded remifentanyl and desflurane. Postoperatively, all
patients were stimulated for early mobilization. Group A
patients with proven OSA had their own CPAP mask with
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them; the mask was applied immediately after extubation
in the operating room or approximately after 30 min in the
post-anesthesia care unit (PACU) for a minimum of 8 h.
During the night the CPAP mask was also used. After
surgery, these patients were monitored using pulse oxim-
etry in the PACU and in the surgical ward.
Study endpoints
For the three groups, we analyzed the following data on the
day of surgery and during postoperative hospital stay:
(1) Pulse oximetry (SpO2; blood oxygen saturation):
postoperative period until the morning of the second
day after surgery (days 0–2, 08:00 to 09:00 AM);
(2) Respiratory rate: postoperative period until the first
morning after surgery (08:00 to 10:00 AM);
(3) LOS: day of admission until day of discharge;
(4) Patient outcome variables: acute myocardial infarc-
tion, cerebrovascular accident, pneumonia, reintuba-
tions, ICU admission rates.
We used the following definitions for the different out-
come variables. Pneumonia was diagnosed by clinical
features (e.g., cough, fever, pleuritic chest pain) and by
lung imaging (X-ray). Myocardial Infarction was diag-
nosed when there is a rise and/or fall of cardiac biomarkers,
along with supportive evidence in the form of typical
symptoms, suggestive electrocardiographic changes, or
imaging evidence of new loss of viable myocardium or
new regional wall motion abnormality. Symptoms are chest
pain and dyspnea [23]. Stroke was defined as rapidly
developing clinical signs of focal (or global) distur-
bance(s) in cerebral function lasting more than 24 h
(except in cases of sudden death or if the development of
symptoms is interrupted by a surgical intervention), with
no apparent cause other than a vascular origin: it includes
patients presenting clinical signs and symptoms suggestive
of subarachnoid hemorrhage, intracerebral hemorrhage, or
cerebral ischemic necrosis [24]. Hypertension was defined
as blood pressure at or above 140/90 mmHg. Reasons for
reintubation were, for example, hypoxia, hypercapnia, and
exhaustion; reasons for ICU admissions were, for example,
hypotension, respiratory problems, (abdominal) sepsis,
bleeding, and re-intervention. Surgical criteria for hospital
discharge included normal mobility, normal respiratory
function, normal cardiac function, no signs of infection,
low pain score (e.g. visual analog score), normal bowel
function, and absence of nausea.
SpO2 was monitored continuously (also during asleep)
postoperatively until the morning of the second night after
surgery (08:00–10:00 AM), and measurements were logged
every 5 min. The SpO2 levels presented in the tables were
measured without oxygen administration to avoid possible
confounding factors. Consequently, if the saturation level
demanded the temporary administration of oxygen, the
SpO2 levels during this period were excluded from the
calculations. The number of patients who needed oxygen
and the number of times after surgery the oxygen was
required were counted and presented in the results. The
respiratory rate (breaths per minute) were measured (dur-
ing sleep and wakefulness) using electrocardiography-
derived respiration during the immediate postoperative
period until the first morning after surgery (08:00–10:00
AM).
Follow-up was verified and adverse events reviewed,
including death, unanticipated transfer or admission to
hospital within 30 days after surgery.
Statistics
Statistical analysis was performed using the SPSS Statistics
ver. 20 program (SPSS Inc., Chicago, IL). One-way ana-
lysis of variance was performed to determine the signifi-
cance of means among the groups. After testing for
homogeneity of variance, we used Tukey’s HSD post hoc
test odds-ratio test to accept or reject the null hypothesis
that portions are equal. p values of \0.05 were considered
to be statistically significant.
Results
A total of 693 patients underwent bariatric surgery (356
RYGB, 337 patients LSG). All patients underwent bariatric
operations without any surgical complications, and none of
the patients were unexpectedly transferred or admitted to
our or another hospital within 30 days after surgery.
Table 1 presents the patient characteristics and the
Table 1 Patient characteristics






Age (years)a 44.5 (7.0) 46.6 (5.3) 46.0 (5.8)












7 (7.9 14 (7.6) 18 (4.4)
Asthma 9 (10.1) 16 (8.9) 21 (5.1)
Diabetes mellitus type 2 14 (15.7) 31 (17.0) 65 (15.8)
Coronary artery disease 15 (16.9) 25 (13.7) 49 (11.9)
Hypertension 31 (34.8) 58 (31.9) 89 (21.6)
a Values given as the mean ± standard deviation (SD)
J Anesth (2014) 28:891–897 893
123
preoperative existing comorbidities. Patients in groups A
and B did not differ significantly in terms of demographics
and the presence of comorbidities (p [ 0.05). The demo-
graphics and presence of comorbidities did differ between
group C and group A/B for hypertension only [p = 0.042
(groups A–C) vs. p = 0.008 (groups B–C)].
Table 2 shows the STOP-BANG results per group dif-
ferentiated to the level of risk for OSA. The odd-ratio
shows no significant difference between patients in the
different risk levels [p = 0.1137 (moderate risk group A–
B) vs. p = 0.4687 (high risk group A–B).
Table 3 presents the distribution of all the STOP-Bang
factors for each patient group, Table 4 shows the compli-
ance rate versus the apnea/hypopnea index (AHI) per
group, Table 5 shows the data on SpO2 and respiratory
rate, and in Table 6 we present other relevant characteris-
tics of the groups. There were no patients with acute
myocardial infarction or cerebrovascular accident.
Group A
A total of 122 patients were originally included in group A.
However, a search of the patient records revealed that 23
patients had reported that they did not use CPAP at all, or
only some nights per week (varying from 0–4 nights per
week) for 0–2 h per night. These patients were excluded
from this group and included in group B, leaving 99
patients (57 RYGB, 42 LSG) in group A.
The compliance rate of this group was 81.8 % {81
patients, average usage 5.9 [standard deviation (SD) 0.8]
h/night; minimum–maximum usage 4.0–9.1 h}. Based on
the PSG test we found that 51 patients had severe sleep
apnea (AHI [30), 32 patients had moderate sleep apnea
(AHI [15), and 16 had mild sleep apnea (AHI 5–15).
In all cases, patients could be safely discharged from
intensive monitoring (reaching the SpO2 [90 %) on the
second day after the bariatric operation. Only in one case,
did a respiratory tract complication (pulmonary embolism)
occur; this patient was treated accordingly. No other
patient was administered oxygen during the postoperative
period. The mean length of LOS in group A for RYGB and
LSG was 3.2 (0.7) and 3.1 (0.4) days, respectively.
Group B
A total of 182 patients were included in group B, of whom 112
(53 RYGB, 49 LSG) scored three to four items on the STOP-
Bang questionnaire (moderate risk) and 70 (30 RYGB, 40
LSG) scored five to eight items (high risk). Included in these
Table 2 Distribution of STOP-BANG scores







High risk: 70 (38.5 %)
Low risk: 412
(100 %)
Table 3 Distribution of positive scored STOP-Bang factors for each
patient group
STOP-Bang factors Group A Group B Group C
Snoring?
Do you snore loudly
(loud enough to be
heard through closed
doors or your partner
has to wear ear plugs
or elbow you at
night)?
91 (91.9 %) 163 (89.0 %) 46 (11.2 %)
Tired?
Do you often feel tired,
fatigued, or sleepy
during the daytime?





71 (71.7 %) 131 (72.0 %) 34 (8.3 %)
Pressure ?
Do you have or are
being treated for high
blood pressure?
86 (86.9 %) 171 (94.0 %) 22 (5.3 %)
Body mass index of
[35 kg/m2?
97 (98.0 %) 182 (100 %) 412 (100 %)
Age older than 50
years?
21 (10.1 %) 44 (24.2 %) 69 (16.7 %)
Neck size large?
For male, is your shirt
collar 17 inches or
larger?
For female, is your
shirt collar 16 inches
or larger?
94 (94.9 %) 103 (97.8 %) 39 (9.5 %)
Gender = male? 72 (72.7 %) 129 (70.9 %) 285 (69.2 %)
Based on STOP-Bang questionnaire [19, 20]. All data are presented as
the score with the percentage in parenthesis
Table 4 Patients in group A: compliance versus the apnea/hypopnea
index
AHI index No. of patients
who complied
No. of patients
who did not comply
Total
AHI [30 49 2 51
AHI [15 29 3 32
AHI 5–15 4 12 16
Total 81 17 99
AHI Apnea/hypopnea index
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182 patients were 23 patients originally from group A who
reported that they did not use CPAP (at all).
In this group the mean value of SpO2 on days 0–2
postoperatively was significantly lower than that of group
A patients (p \ 0.0001). On days 0–1 the respiratory rate in
group B had a larger variation and was significantly lower
than those of group A and C. Sixteen patients received
oxygen in the postoperative period; this occurred between
1 and 14 h after surgery and the duration of oxygen
administration varied between 20 and 45 min. Further
analysis (not shown) revealed that there was no difference
between the RGB/LSG patients. The mean LOS was 4.1
(0.5)/4.2 (0.6) days (RGB/LSG), which is significantly
(p \ 0.001) longer than that for group A. The percentage
of complications did not differ significantly from that of the
other groups. In this group we also noted two cases of
sudden death, both of which took place during the night on
the second postoperative day. These patients (I and II) were
two males aged 34 and 41 years, respectively. Patients (I/
II) had a BMI of 44/46 kg/m2 and had scored four/six items
on the STOP-Bang. Both had hypertension and diabetes
and snored loudly during hospitalization (before and after
surgery). Both patients also presented with signs and
symptoms of dyspnea and hypoxia (SpO2 \ 90 %) on the
day of surgery (day 0) and the first postoperative day. For
patient I, we also observed high blood pressure which
required antihypertensive drugs. Autopsy revealed that
both patients died because of sudden cardiac death caused
by asphyxia.
Group C
There were 412 (221 RYGB, 181 LSG) patients in this
group, all of whom scored one or two items on the STOP-
Bang. In this group the respiratory parameters and LOS
were significantly better than in those group B, and there
was no significant difference with group A.
Discussion
Our results show that morbidly obese patients diagnosed
with OSA by a PSG test and who are using CPAP have
fewer perioperative complications and a shorter hospital
stay than patients whose medical history meets at least
three STOP-Bang criteria and who are not using CPAP.
Table 5 Mean blood oxygen
saturation and respiratory rates
in the patient groups
Data are given as the mean with
the SD in parenthesis
SpO2 Blood oxygen saturation,
RR respiration risk
* Significant at the 5 % level










SpO2 (%) day 0 92.1 (1.4) 90.8 (1.6) 94.8 (1.2) \0.0001* \0.0001*
SpO2 (%) day 1 94.3 (1.2) 90.6 (1.3) 96.6 (1.3) \0.0001* \0.0001*
SpO2 (%) day 2 96.6 (1.1) 94.8 (1.4) 98.4 (1.5) \0.0001* \0.0001*
RR (breaths/
min) on day 0
15.8 (1.9) 12.4 (2.4) 16.1 (0.9) \0.0001* \0.0001*
RR (breaths/
min) day 1
16.6 (1.4) 13.6 (2.9) 18.0 (0.7) \0.0001* \0.0001*
Table 6 Characteristics of the
groups












7 AHI [ 30





Deaths (n) 0 2 0 0.5142 0.3807
Length of stay
(mean, SD)
3.2 (0.7) 4.1 (0.5) 2.5 (0.6) 0.0001* \0.0001*
Pneumonia (n) 2
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They also indicate that when the severity of OSA is known
one can take more appropriate measures to reduce the risk
of complications and reduce LOS in hospital. Our findings
confirm that it is essential to address the burden of mor-
bidly obese patients diagnosed with OSA to public
healthcare systems and to develop cost-effective case-
finding strategies and feasible treatments for OSA [1]. Our
findings are opposite to those reported by Kaw et al. [25]
who reported that non-cardiac patients with OSA
(AHI C 5) were are at higher risk of postoperative hyp-
oxemia, ICU transfers, and longer LOS. However, these
authors did not differentiate between the specific type of
procedure (bariatric), and the average BMI of these patients
was lower. It is known that the more specific the group of
patients, the more precisely the outcomes can be defined.
Hence, this may explain the difference in complications
and LOS between the two studies. In our study we found
that the higher the AHI index, the higher the compliance.
Earlier findings are not clear in terms of determining
whether there is a causal relation between AHI and com-
pliance [33]. Our results confirm those of earlier studies
demonstrating a relation between diagnosed OSA (not
using CPAP) and an increased incidence of postoperative
complications, with the most frequent being oxygen
desaturation [27–29].
In our study we show a negative effect on LOS whereas
other studies [29] showed a mixed impact. For the final
diagnosis of OSA, PSG tests are essential. To our knowl-
edge, there have as yet been no double-blinded randomized
studies in a preoperative assessment setting showing the
outcomes of PSG tests versus questionnaires. It would
appear reasonable to ask if a PSG is always necessary when
a patient scores three or more items on the STOP-Bang
questionnaire. The PSG test is relatively costly [30], and
the STOP-Bang does has highly prognostic value for OSA
[20, 21]. From the economic point of view the use of CPAP
also reduces the LOS in hospital and hence reduces costs
per patients admitted. All other things being equal, a
shorter stay may reduce the cost per discharge and shift
care from inpatient to less expensive post-acute settings.
Also, OSA is related to severe respiratory complications
and ICU admission. Reducing costs by identifying and
treating risk patients with CPAP and consequently avoiding
the expensive use of ICU facilities is desirable [31, 32].
There are a number of limitations to our study. As this is
a retrospective study, it can show association but not
causality. Moreover, the study population is relatively
small. Larger randomized case–control studies are needed
to confirm our results. Although we have information about
the STOP-Bang results for groups A and B, the severity for
OSA in Group A is objectively determined by the PSG test.
Although we may assume that patients in Group B scoring
five to eight items on the STOP-Bang have an elevated risk
for OSA, the severity of OSA is still not clear. It may be
that these patients on average have a higher median AHI
score when diagnosed for OSA and that this result may
then (partially) explain the higher postoperative compli-
cations in group B.
Based on our results, we conclude that patients meeting
at least three STOP-BANG criteria can be expected to have
higher postoperative complications and an increased LOS
than patients using CPAP.
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